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Skeletal muscle atrophy can result from a range of physiological conditions, including denervation.
To better characterize the molecular genetic events of atrophy, skeletal muscle was isolated from
mice following 3 and 14 days of denervation. The gene expression profile of the denervated
muscle tissue was analyzed by microarray and compared to control muscle to identify novel
atrophy-induced genes. The microarray revealed that Fggy carbohydrate kinase domain containing
(Fggy) is expressed in skeletal muscle and is induced in response to denervation. Bioinformatic
analysis of the Fggy gene locus revealed two validated alternative isoforms, which we have termed
Fggy-001 and Fggy-003, which have distinct transcription initiation sites. In order to confirm that
Fggy is expressed in muscle cells, the cDNA of the two validated alternative variants was cloned
from mouse myoblast cells. Interestingly, a novel alternative splice variant for each of the validated
alternative isoforms was also cloned from mouse muscle cells, suggesting at least four Fggy splice
variants to be expressed in skeletal muscle. Quantitative RT-PCR (RT-qPCR) was performed using
RNA isolated from muscle cells and primer pairs that distinguish the four alternative Fggy
transcripts. The RT-qPCR data reveals that all four Fggy transcripts are more highly expressed in
differentiated myotubes, compared to proliferating myoblasts. Additionally, ectopic expression of
Fggy-001 and Fggy-003 resulted in inhibition of muscle cell differentiation and attenuation of the
MAP kinase signaling pathway. Finally, confocal fluorescent microscopy analysis revealed that the
Fggy-001 transcripts appear to localize to the cytoplasm, while the Fggy-003 transcripts produce a
more punctuate localization pattern throughout the cytoplasm of proliferating muscle cells. The
characterization of novel genes that are activated during neurogenic atrophy helps improve our
understanding of the molecular and cellular events that lead to muscle atrophy and could
eventually lead to new therapeutic targets for the treatment of muscle wasting.
Skeletal muscle atrophy results in muscle weakening through the decrease in cross sectional
areas of myofibril as protein degradation surpasses protein synthesis (1). Many genes are involved
in the intricate pathway that results in muscle wasting. In order to understand what occurs during
skeletal muscle wasting, Bodine et al conducted a study which induced muscle atrophy in rats (1).
They found two genes to be significantly upregulated in all models of muscle atrophy: MuRF1
and MAFbx (1). MuRF1 and MAFbx were both identified as ubiquitin E3 ligases that are believed
to tag specific proteins for degradation or modification. To better characterize skeletal muscle
wasting, Furlow et al conducted a microarray analysis of whole genome expression of the
gastrocnemius muscle isolated from wild-type mice and MuRF1 knockout mice following 3 days
and 14 days of denervation (2). They found that many genes were differentially expressed under
atrophy conditions, including a carbohydrate kinase referred to as Fggy (4). The research
presented here is an extension of the microarray study conducted by Furlow et al on the Fggy




Figure 2. Schematics of alternative transcripts of the Fggy gene in mouse. (A) Schematic of the Fggy-001
transcript and the location of the microarray probe (red asterisk). Fggy-001 has 16 exons and 15 introns. The
Fggy-001 alternative transcript is missing exons 10 and 11 (red circle Figure 2A). (B) Schematic of the Fggy-
003 transcript. The microarray probe did not recognize the Fggy-003 transcript. Fggy-003 has 11 exons and
















































Figure 1. Fggy is induced in response to denervation-induced skeletal muscle atrophy. Whole genome
expression analysis was conducted on gastrocnemius muscle from MuRF1-null (KO) and wild-type (WT)
mice after (A) 3 days (3D) and (B) 14 days (14D) of denervation. Significant increase following denervation
in wild-type and MuRF1-KO mice (* p<0.01) is seen at 14 days post-denervation.
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Figure 3. Confocal microscopy of the Fggy-001 FL, Fggy-001 Alt, Fggy-003-FL, and Fggy-003 Alt
transcripts fused to GFP in muscle cells. (A-C) Fggy-001-FL shows expression in both the cytoplasm and the
nucleus. (D-F) Fggy-001-Alt shows expression only in the cytoplasm and appears to be excluded from the
nucleus, suggesting that exon 10 and/or 11 may have a nuclear localization signal. (G-I) Fggy-003-FL shows
expression only in the cytoplasm. (J-L) Fggy-003-Alt shows punctate cytoplasmic localization.
 Fggy expression was induced in MuRF1-null and wild-type mice following denervation-
induced atrophy.
 Fggy expression increased significantly in wild-type mice following 3 and 14 days of
denervation, while MuRF1-null mice showed no significant change in expression at 3 and 14
days post-denervation (Figure 1).
 Two transcripts of the Fggy gene were identified and cloned from mouse muscle cells along
with novel isoform of each transcript (Figure 2).
 All four transcripts were tagged with GFP to visualize the cellular localization of Fggy in
murine muscle cells. It was found that Fggy exhibited nuclear exclusion in all transcripts except
Fggy-001-FL (Figure 3).
 Western Blot analysis suggests that the Fggy-001-FL transcript overexpression inhibits C2C12
differentiation when probed for Myosin Heavy Chain and myogenin which are established
markers of muscle cell differentiation. Western blot analysis also unveiled a decrease in ERK
phosphorylation (Figure 4).
 The role of the ERK protein in the Mitogen Activated Protein Kinase (MAPK) cascade and the
effect that the overexpression of Fggy had on it, foreshadowed the results of the AP-1 reporter
assays conducted with all four transcripts. The overexpression of Fggy led to a decrease in AP-
1 reporter activity in all transcripts, most significantly at the later differentiation time points,
when compared to control (Figure 5).
1. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Pouymirou WT, Panaro FJ, Na E,
Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. 2001.
Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy. Science 294: 1704-1708.
2. Furlow J, Watson M, Waddell D, Neff E, Baehr L, Ross A, Bodine S. 2013. Altered gene expression
patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle
atrophy. Physiological Genomics 45: 1168-1185.
3. Bodine C, Baehr L. 2014. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and
MAFbx/atrogin-1. American Journal of Physiology Endocrinology and Metabolism 307: E469-E484.
4. Zhang Y, Zagnitko O, Rodionova I, Osterman A, Godzik A. The Fggy Carbohydrate Kinase Family:
Insights into the Evolution of Functional Specificities: e1002318.PLoS Computational Biology 7(12): 1-
13.
This work was supported by UNF start-up funds, Transformational Learning Opportunity (TLO)
grants, UNF Foundation Board Grant, and COAS Dean’s Leadership Council Fellowship awards
to D.W.
Figure 4. Western Blot analysis of Fggy-001-FL protein over expression probed for differentiation markers
and MAPK signaling pathway intermediates. Western blot analysis was performed on proliferating (P) and
differentiated (D) C2C12 cells harvested over a ten day time course. Cells were maintained in proliferation media
(10% serum) and harvested 2 days post-plating. Cells were then switched to differentiation media (2% serum)
and harvested at 1, 3, and 5 days post-media change. The western blot suggests that Fggy overexpression results


















Figure 5. Fggy overexpression attenuates the MAPK signaling pathway. C2C12 cells were transfected with
either a reporter gene with an AP-1 consensus element alone (white bar) or in combination with 1 ug of the
Fggy pcDNA cDNA expression plasmid (black bar) and culture media was analyzed over a 6-day time-course.
Cells were maintained in proliferation media (10% serum) 2 days post-plating and then switched to
differentiation media (2% serum).
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